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The patient’s delay in the visit to a hospital seems to play an important role in prognosis in invasive cutaneous squamous cell
carcinoma (SCC). This report explored prognostic factors of cutaneous SCC focusing on patient delay in hospital visit. Data of
117 Japanese patients who were treated for invasive cutaneous SCC in our facility between 2000 and 2010 were used for analysis.
A multivariate Cox proportional-hazard modelling revealed that a pair of TNM stage (hazard ratio, 5.0; 95% CI, 1.8 to 13.9) and
poorer histological diﬀerentiation (hazard ratio, 3.2; 95% CI, 0.93 to 10.3), and a pair of tumour size (hazard ratio, 1.02; 95% CI,
1.004to1.04)andrapidgrowth(hazardratio,8.25;95%CI,1.29to52.7)wereaprognosticfactorwhereaspatientdelayinhospital
visit was not. However, patient delay in hospital visit was correlated with larger tumour size.
1.Introduction
Cutaneous squamous cell carcinoma (SCC) is a malignant
tumour of keratinocytes that tends to metastasise and leads
to mortality. In cutaneous SCC, a number of clinical and
histological factors have been found to be poor prognostic
factors. For example, tumour size, gender, preceding lesion,
histological ﬁndings such as degree of the diﬀerentiation,
and tumours location have been reported as a prognostic
factor of local recurrence, metastasis, and disease-speciﬁc
death [2–5]. In addition, recent research has pointed out that
delay before surgical removal is an independent prognostic
factor because delay may lead to more advanced stage [4]. In
this observational study, we attempted to explore prognostic
factors of cutaneous SCC, especially paying attention to the
eﬀect of patient delay in hospital visit. We hypothesised
the structure that prolonged patient’s delay in the visit to a
hospital aﬀects stage and prognosis consequently.
2. Patientsand Methods
A patient registry system from the Department of Dermatol-
ogy at the Kyoto University Hospital was accessed to retrieve
medical information on patients in whom invasive SCC of
the skin was histopathologically diagnosed and treated from
2000 to 2010. During that period, one hundred and forty-
nine patients were retrieved. Twenty cases were excluded
because of tumour in situ, and two cases because of lack in
clinical and pathological information. Ten cases with genital
S C Cw e r ee x c l u d e db e c a u s eo fd i ﬀerent staging system.
The remaining 117 Japanese patients who were treated for
invasive cutaneous SCC were eligible for analysis. Followup
was performed every 3 to 6 months by physical examination
and blood works. A mean followup was 29.9 months.
Variables were demographic characteristics, TNM stage of
cutaneous squamous cancer (UICC 7th edition, 2009) [1],
tumoursite,histopathologicalﬁndings(diﬀerentiationofthe
tumour, perineural invasion, and lymphovascular invasion),
rapid growth [6], radiation therapy, and preceding condition
of tumour site. Degree of the diﬀerentiation was rated on
an ordinal scale of poor, moderate, or well diﬀerentiated.
Perineural invasion, lymphovascular invasion, rapid growth,
radiation therapy, and preceding condition of tumour site
were collapsed into dichotomous variables, with 0 as indica-
tive of negative and 1 as indicative of positive. Patient delay
in hospital visit was deﬁned as time taken before hospital
visit with complaint of SCC since the patient had noticed the
lesion. Primary endpoint was set as disease-speciﬁc death.2 ISRN Dermatology
2.1. Statistical Analysis. Descriptive statistics were calculated
to estimate the frequencies, means, and standard deviations
ofthestudyvariables.Survivalanalyseswereconductedfrom
the date when a patient had noticed the tumour to the date
of death with use of the Kaplan-Meier method. Data from
patients who were alive at the study followup (31, December,
2010) were censored on that date.
Preliminary analysis was conducted exploring whether
patient delay in hospital visit varies according to change of
other prognostic factors. As distribution of patient delay in
hospital visit was skewed right, Spearman rank correlation
coeﬃcients and Mann-Whitney U test were used.
Then, a Cox proportional-hazards model was used for
univariate and multivariate analysis to evaluate the eﬀect of
predictors on disease-speciﬁc survival [7]. First, the signiﬁ-
cant predictors on the survival were screened via univariate
analysis. Second, variables that had signiﬁcant contribution
on survival in univariate analysis were entered into the
multivariate model, followed by a backward elimination
procedure that was used with P based on Wald statistics
higher than 0.1 for variable removal from the model. As
a pair of stage and tumour size showed multicollinearity,
either of them was used for the initial multivariate model.
The results were adjusted for age. The SPSS 12.0 (SPSS
Inc., Chicago, Ill, USA) was used for all statistical analyses.
Missing values were excluded from each analysis. All given
probabilities are two tailed and the signiﬁcance levels were
set at 5%.
3. Results
A total of 117 patients were included into the analysis. The
characteristics of the patients were shown in Table 1.T h e
mean age of patients was 74.4 ± 12.7y e a r s( r a n g e ,3 0t o
98 years); 74 (63%) were male. SCC occurred frequently
in the cheek (21%), lower extremities (16%), and ear
(8.5%). Actinic keratosis (25%) was most frequent preceding
condition, followed by Bowen disease (15%), both of which
are associated with sun exposure (Table 1). Patient delay was
2.97 ± 4.1 years and did not signiﬁcantly diﬀer amongst
locations of tumour. Of 117 patients, there were 8 deaths
(6.8%) recorded as caused by squamous cell carcinoma
during the follow-up period. The 5-year survival rate was
87% in total. One hundred percent for stage I, 82% for
stages II, 83% for stage III. All cases of stage IV were dead
or censored within 6 months. Survival curves of Stage II
and III did not diﬀer signiﬁcantly (Log rank statistics 0.29,
P = 0.59).
Preliminary analysis revealed that patient delay in hospi-
tal visit was associated with other prognostic determinants.
Longer patient delay was signiﬁcantly correlated with larger
tumour size (Spearman rho rank correlation coeﬃcient =
0.20, P = 0.04) and less rapid growth (Mann-Whitney U =
50,P = 0.049).
Of 117, eighty-eight cases were considered in the Cox
regression analysis, as 18 cases had missing values, and 11
cases were censored before the earliest event occurred. In
Table 1: Characteristics of the patients, given as mean ± standard
deviation or no, (%) (N = 117).
Prognostic factor Number (%)
Sex, male (%) 74 (63)
Age (year) 74.4 ±12.7
Patient delay in hospital visit (year) 2.97 ±4.1
Tumour size (mm) 28.3 ±28.7
Lymph node metastasis 12 (10.3)
TNM stage(1)
Stage I 56 (47.9)
Stage II 38 (32.5)
Stage III 17 (14.5)
Stage IV 6 (5.1)
Radiation related 3 (2.6)
Rapid growth 7 (6.0)
Perineural invasion 3 (2.6)
Lymphovascular invasion 3 (2.6)
Degree of diﬀerentiation
Well 67 (57.3)
Moderate 27 (23.1)
Poor 7 (6.0)
Tumour site
Temporal head 8 (6.8)
Frontal head 4 (3.4)
Eye lid 1 (0.9)
Cheek 24 (20.5)
Ear 10 (8.5)
Nose 4 (3.4)
Lip 5 (4.3)
Upper extremities 5 (4.3)
Finger 8 (6.8)
Hand 8 (6.8)
Trunk 6 (5.1)
Lower extremities 19 (16.2)
Planter of the foot 3 (2.6)
Dorsum of the foot 3 (2.6)
Heel 2 (1.7)
Digit of the foot 7 (6.0)
Preceding lesion
Actinic keratosis 29 (24.8)
B a s a lc e l lc a r c i n o m a 1( 0 . 9 )
Bowen disease 17 (14.5)
Burn 3 (2.6)
Epidermal cyst 1 (0.9)
Keratoacanthoma 6 (5.1)
Pustulosis palmaris and plantaris 1 (0.9)
Radiation keratosis 1 (0.9)
Scar 4 (3.4)
Other squamous cell carcinoma 1 (0.9)
Trichilemmal cyst 1 (0.9)
Ulcer 10 (8.5)
Unknown 42 (35.9)
Note: (1)Stage was described using UICC (7th edition, 2009) [1].
univariate analysis tumour size, TNM stage, rapid growth,
lymphovascular invasion, and the diﬀerentiation were iden-
tiﬁed as a signiﬁcant determinant, while patient delay in
hospital visit, age, and sex were not. Multivariate model
revealed that a pair of TNM stage and poorer histological
diﬀerentiation and a pair of tumour size and rapid growth
were a prognostic factor (Table 2).ISRN Dermatology 3
Table 2: Prognostic factors of cutaneous squamous cell carcinomas inﬂuencing overall survival: results of univariate and multivariate Cox
proportional hazard models.
Prognostic factor
Univariate model Multivariate model 1(1) Multivariate model 2(1)
HR 95% CI P HR 95% CI P HR 95% CI P
Age 1.02 0.96–1.08 0.57 1.02 0.94–1.1 0.58 1.04 0.97–1.12 0.27
Patient delay in hospital
visit 0.97 0.79–1.19 0.78
Sun exposure (positive = 1) 1.83 0.37–9.10 0.46
Tumour size 1.02 1.01–1.04 0.01 1.02 1.004–1.04 0.01
Lymph node metastasis
(positive = 1) 3.03 0.61–15.10 . 1 8
TNM Stage(2) 4.02 1.60–10.1 0.04 5.02 1.79–14.10 . 0 0
Radiation related (true = 1) 4.90 0.63–40.20 . 1 4
Rapid growth (positive = 1) 7.60 1.49–39.1 0.02 8.25 1.29–52.70 . 0 3
Perineural invasion
(positive = 1) 4.50 0.55–36.40 . 1 6
Lymphovascular invasion
(positive = 1) 8.15 0.942–70.60 . 0 6
Degree of diﬀerentiation 2.99 1.27–7.64 0.02 3.20 0.94–10.90 . 0 6
Note: The total number of cases was 117; of those, 88 were considered in the analysis, as 18 cases had missing values, and 11 cases were censored before the
earliest event occurred. There were 8 deaths recorded as caused by squamous cell carcinoma.
(1)Variables that were signiﬁcant in univariate analysis were entered into the model, followed by a backward elimination procedure with P>0.1f o rv a r i a b l e
removal from the model. In model 3, tumour size was used instead of TNM stage. The results were adjusted for age. CI: conﬁdence interval; HR: hazard ratio.
(2)Stage was described using UICC (7th edition, 2009).
4. Discussion
The current study addressed the question whether patient
delay in hospital visit and other factors aﬀect the prognosis
of invasive cutaneous SCC using multivariate analysis. As
expected, tumour size, TNM stage, diﬀerentiation of the
tumour [2, 3], and rapid growth were thought to be a
prognostic factor, while patient delay in hospital visit was
not.
Based on the literature [4], we ﬁrst hypothesized that
patients with longer patient delay in hospital visit had been
prone to advanced disease and poor prognosis. In this study,
correlation analysis revealed only the weak tendency that
prolonged delay was associated with slower tumour growth
and larger tumour size that is an important prognostic factor
of cutaneous SCC. In other words, patients tend to postpone
their visit to a hospital only in case the tumour grows slowly,
which leads to larger tumour as a result. This tendency was
conﬁrmed by the fact that the signiﬁcance of the correlation
between patient delay in hospital visit and tumour size
was maintained at a slightly elevated level when speed of
tumour growth was partialed out. Although patient delay in
hospital visit was not directly associated with prognosis, it
can be said that patient delay may indirectly aﬀect prognosis
of cutaneous SCC. Further public announcement seems
important to encourage people to consult a dermatologist
when they notice skin tumours so as to shorten the delay in
hospital visit.
In contrast, the diﬀerentiation of tumour was shown to
be an independent prognostic factor as has been expected.
As diﬀerentiation of tumour is not considered when staging,
careful followup is required for cases with cutaneous SCC of
poor diﬀerentiation irrespective of stage.
In this study, patients with genital SCCs were not
considered because of diﬀerent staging system and small
sample size. Genital SCCs tended to be at more advanced
stage and of poorer diﬀerentiation than SCCs in other
site at the time of diagnosis [8]. This phenomenon may
be explained by human papilloma virus (HPV) infection
because community-based epidemiological study revealed
that HPV infection in genital area is associated with cancer-
related death [9]. HPV infection may accelerate tumour
progress of cutaneous SCC.
Several limitations of the study deserve mention. First,
this study was conducted at a single medical facility and
consisted of a relatively smaller sample, thereby limiting
generalization of the results to patients of other hospitals. In
addition, because the sample lacked diversity with respect to
race,wewereunabletoassesstheeﬀectofthatimportantfac-
tor on outcomes. However, our study reﬂects the prognostic
factors of cutaneous SCC in Japanese population.
In summary, our study showed that tumour size, TNM
stage, diﬀerentiation of the tumour, and rapid growth were
thought to be a prognostic factor, while prolonged patient
delay seems to aﬀect indirectly the prognosis by inﬂuencing
larger tumour size.
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